All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-32742035

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32742035	D614G	S	S	COVID-19	R	View
2	32742035	P323L	RdRp	ORF1b	COVID-19	R	View
3	32742035	L84S	ORF8	ORF8	COVID-19	R	View
4	32742035	Q57H	ORF3a	ORF3a	COVID-19	R	View
5	32742035	L3606F	NSP6	ORF1a	COVID-19	R	View
6	32742035	C3037T	NSP3	ORF1a	COVID-19	R	View
7	32742035	448delD	NSP2	ORF1a	COVID-19	R	View
8	32742035	G392D	NSP2	ORF1a	COVID-19	R	View
9	32742035	T265I	ORF1ab	ORF1ab	COVID-19	R	View
10	32742035	P4715L	ORF1ab	ORF1ab	COVID-19	R	View
11	32742035	L37F	NSP6	ORF1a	COVID-19	R	View
12	32742035	A58T	NSP3	ORF1a	COVID-19	R	View
13	32742035	P153L	NSP3	ORF1a	COVID-19	R	View
14	32742035	T85I	NSP3	ORF1a	COVID-19	R	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.